1. Immunology/Inflammation
  2. Interleukin Related
  3. Anti-Mouse IL-6R Antibody (15A7)

Anti-Mouse IL-6R Antibody (15A7) 

Cat. No.: HY-P990211 Purity: 98.47%
Technical Support

Anti-Mouse IL-6R Antibody (15A7) is a rat-derived anti-mouse IL-6R IgG2b κ type antibody inhibitor. Anti-Mouse IL-6R Antibody (15A7) blocks IL-6 binding to IL-6Rα and inhibits both IL-6 classic and trans-signaling. Anti-Mouse IL-6R Antibody (15A7) can be used for the researches of cancer and inflammation, such as triple-negative breast cancer.

For research use only. We do not sell to patients.

Anti-Mouse IL-6R Antibody (15A7)

Anti-Mouse IL-6R Antibody (15A7) Chemical Structure

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Anti-Mouse IL-6R Antibody (15A7) is a rat-derived anti-mouse IL-6R IgG2b κ type antibody inhibitor. Anti-Mouse IL-6R Antibody (15A7) blocks IL-6 binding to IL-6Rα and inhibits both IL-6 classic and trans-signaling. Anti-Mouse IL-6R Antibody (15A7) can be used for the researches of cancer and inflammation, such as triple-negative breast cancer[1][2][3][4].

Isotype

Rat IgG2b kappa

Recommend Isotype Controls
Species Reactivity

Mouse

IC50 & Target

IL-6R

In Vitro

The antibody framework is stable, specific and adaptable, and has the ability to bind both antigens and endogenous immune receptors. Monoclonal antibodies have several derivatives, including bispecific antibodies, antibody-drug conjugates, and antibody fragments, and have significant effects in fields such as immunology and oncology. When designing inhibitory antibodies, considerations include identification of antigen-specific variable regions, choice of expression system, use of multispecific formats, and antibody derivatives based on fragmentation, oligomerization, or conjugation with other functional moieties[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Anti-Mouse IL-6R Antibody (15A7) (100 μg, i.v., a single dose) inhibits leukocyte accumulation in air pouch mice model of local inflammation[1].
Anti-Mouse IL-6R Antibody (15A7) (2.5 mg/kg, i.v., semiweekly for 3 weeks) shows anti-tumor effect in triple-negative breast cancer mice models[2].
Anti-Mouse IL-6R Antibody (15A7) (10 mg/kg, i.p., after 6 h of IL-1α injection) efficiently crosses the maternal–foetal interface, restores foetal growth, and dampens foetal inflammation in pregnant IL-1α-induced inflammation mice models[3].
Anti-Mouse IL-6R Antibody (15A7) (0.5-3 mg, s.c., 24 h before T1033C2 injection) inhibits tumor growth and increases survival rate in T1033C2 plasmacytoma mice models[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Triple-negative breast cancer mice models[2]
Dosage: 2.5 mg/kg
Administration: Intravenously injection, semiweekly for 3 weeks
Result: Increased survival rate.
Inhibited postsurgical lung nodules metastasis.
Reduced CD163(+) M2 macrophage and Foxp3(+) Treg infiltration.
Animal Model: IL-1α-induced systemic inflammation mice models (pregnant)[3]
Dosage: 10 mg/kg
Administration: Intraperitoneally injection, after 6 h of IL-1α injection
Result: Could be detected in the intraamniotic space.
Prevented the IL-1α-induced expression of Ccl3, Nlrp3, Il12a, and Lrg1 in the placenta.
Decreased TNF and IL-6 levels.
Prevented the IL-1α-driven dysregulation of Il1a, Il1b, Tnf, and Lrg1 in the foetal brain, P2rx7 in the foetal lung, and S100a9 in the foetal intestine.
Protected against IL-1α-induced foetal growth restriction.
Improved adverse neonatal outcomes induced by intra-amniotic IL-1α.
Restored IL-1α-induced neonatal gut immune-microbiome alterations.
Animal Model: T1033C2 plasmacytoma mice models[4]
Dosage: 0.5-3 mg
Administration: Subcutaneously injection, 24 h before T1033C2 injection
Result: Showed protection rate of 60%.
Gene ID

16193  [NCBI]

Accession
Application

ELISA, FACS, Functional assay, Research in vivo

Conjugated

Unconjugated

Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.

Molecular Weight

150 kDa

Appearance

Liquid

Color

Colorless to light yellow

SMILES

[Anti-Mouse IL-6R Antibody (15A7)]

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Purity: 98.47%

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anti-Mouse IL-6R Antibody (15A7)
Cat. No.:
HY-P990211
Quantity:
MCE Japan Authorized Agent: